Pharmaceutical giant Pfizer shared promising results Thursday regarding its COVID-19 booster dose for children aged 5 to 11. The company said that an additional shot of...
A third vaccine dose increased antibodies in kids 5 to 11 against the Omicron strain, Pfizer says | Fortune You need to enable JavaScript to view...
Pfizer CEO Albert Bourla on developing a COVID vaccine in less than a year | Fortune You need to enable JavaScript to view this site.
Two studies published Monday concluded that the risk of heart inflammation following COVID-19 vaccination is quite low. A study published in the American Heart Association’s journal...
The United States has reportedly lent its support to a multilateral agreement to waive intellectual property rights on COVID-19 vaccines. Proponents of the waiver would have...
In a meeting that took place Wednesday, the Food and Drug Administration said that regulators need to determine if additional or different COVID-19 vaccines will be...
In a study published Tuesday by the Centers for Disease Control and Prevention, the national health agency advised recipients of Johnson & Johnson’s single-dose vaccine to...
New data on the omicron variant wave is seemingly casting doubt on the efficacy of the Johnson & Johnson vaccine after recording more deaths than the...
The COVID-19 pandemic appears to be not going anytime soon after entering its second year this 2022. Should it continue for many more years, experts believe...
According to a study published in The Journal of the American Medical Association, Johnson & Johnson’s single-dose vaccine may provide even more immunity than its Pfizer...
Recent Comments